Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Intensive Care Medicine (2021) - Comments
pubmed: 34251506  doi: 10.1007/s00134-021-06448-5  issn: 0342-4642  issn: 1432-1238